{"title":"Ocrelizumab - what we know, what we can improve now, what we can improve in the future","authors":"M. Elišák","doi":"10.36290/neu.2024.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":502927,"journal":{"name":"Neurologie pro praxi","volume":"80 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologie pro praxi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36290/neu.2024.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}